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Objective: To compare Transforming growth factor-β1 (TGF-β1) expression in various L-PRF 
concentrations on the hDPSC differentiation process. Material and Methods: hDPSC cell cultures were 
subjected to serum starvation by reducing FBS levels in the hDPSC culture media. Lysate PRF was 
obtained from the PRF gel, which was then incubated at 4°C for 24 h. The supernatant was dried, 
transferred to a 2-ml Eppendorf tube, and stored at −20°C. The evaluation of TGF-β1 expression in 1%, 
5%, 10%, and 25% L-PRF samples and 10% FBS (control) during the process of hDPSC differentiation was 
quantified using an ELISA reader on day 7. The expression of TGF-β1 was subjected to a one-way ANOVA 
test, followed by Bonferroni’s post hoc test with significant values (p<0.05). Results: Significant differences 
were noted in TGF-β1 expression between 1%, 5%, 10%, and 25% L-PRF and the control group (10% FBS). 
The highest TGF-β1 expression occurred with 25% L-PRF (0.645 ± 0.048), followed by 10% L-PRF (0.461 
± 0.035), 10% FBS (0.374 ± 0.013), 5% L-PRF (0.275 ± 0.045), and the lowest expression was with 1% L-
PRF (0.160 ± 0.045). Conclusion: The best result of TGF-B1 expression in hDPSC differentiation was in 
the 25% L-PRF group. 
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Regenerative endodontic treatment (RET) has led to a paradigm shift in endodontic treatment 
through pulp regeneration. It was reported that RET was based on the basic principles of tissue engineering, 
which involves three main components: stem cells, a scaffold comprising an extracellular matrix framework, 
and growth factors as signaling proteins [1-3]. Transforming growth factor-β1 (TGF-β1) is a polypeptide 
member of the beta cytokine transformation superfamily. This protein is secreted to perform many cellular 
functions, including cell growth, proliferation, differentiation, senescence, and apoptosis [4]. TGF-β1 can 
initiate the differentiation of human dental pulp stem cells (hDPSCs) into several other cell types through 
limited lineages or multipotent, such as odontoblasts. TGF-β plays an important role in reducing the number 
of DNA (Id) binding protein inhibitors, known as inhibiting factors for protein differentiation. Moreover, TGF 
β1 also regulates the transition process, from proliferation to differentiation, so that the process will be stopped 
and continue to differentiation process [5]. 
Previous authors developed second-generation platelet concentrates without anti-coagulant 
ingredients [6]. These platelets can be concentrated in the top layer of a tube after a single centrifugation 
process at a speed of 2,700 rpm (750 g) for 12 minutes [7]. This autologous concentrate is known as PRF, 
which has a high fibrin matrix content. PRF also contains a large number of white blood cells, which can 
support tissue healing by increasing immune responses and securing a large number of growth factors for a 
long time, between 7 and 14 days [8]. Modifications to the process for manufacturing PRF can be carried out 
by performing a freezing liquefaction process, which aims to lyse platelets and collect the growth factors 
released upon their lysis. This modification results in PRF lysate (L-PRF) [9]. 
Saeed et al. [8] revealed the effectiveness of 1% PRF exudates in hDPSC differentiation on day 7 have 
the superior ability for osteo differentiation by Alizarin Red staining and calcium mineral deposits. Abuarqoub 
et al. [9] used lysate derived from PRP as a culture medium for hDPSC and SCAP differentiation. His study 
showed that 5% PRP lysate had the highest DSPP expression among all groups. DSPP is a non-collagen 
protein that induces mineralization in the extracellular matrix and is not found in other tissues; therefore, it 
can be used as a phenotype marker of odontoblast activity [9]. 
Another study evaluated the platelet distribution pattern and the release of different growth factors 
(VEGF, TGF-β1, and EGF) in three PRF matrices (PRF, A-PRF and A-PRF+); it was concluded that the 
release of growth factors was significantly higher on days 7 and 10 [10]. The expression of TGF-β1 in other 
stem cells' differentiation process has been previously analyzed; the present study was conducted to analyze 
differences in TGF-β1 expression in various concentrations of L-PRF. 
 
Material and Methods 
Laboratory Procedures 
All work procedures were performed in a biohazard cabinet under sterile conditions. Samples of 
hDPSCs were obtained from previous research (no. 35/ethical approval/FKGUI/V/2018, no. Protocol: 
090250218), and serum starvation was performed by reducing FBS levels in the hDPSC culture media. 
Initially, the culture medium was supplemented with 10% FBS; following the second and third 
passage, the cells were harvested and the culture medium was replaced with DMEM, which was added 
together with 1% FBS for 24 hours. Using a disposable syringe, 10 ml of blood was taken from three different 
donors from the cubitus vein. Within 2 min of collecting the blood, it was centrifuged at 2700 rpm for 12 min. 
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This resulted in two layers: the PRF gel at the top and red blood cells at the bottom. The PRF gel layer was 
removed using sterile tweezers and placed in a sterile tube. 
To obtain L-PRF, the PRF gel was incubated for 24 h at 4°C after it was confirmed that the 
remaining fibrin was attached to the bottom of the tube. The supernatant was dried, transferred to a 2 ml 
Eppendorf tube, and stored at -20°C. The supernatant comprised platelet lysate. Lysate platelets were made in 
four concentrations consisting of 1%, 5%, 10%, and 25%. Concentration dilution was performed using DMEM 
(Dulbecco's Modified Eagle Medium, Gibco, Thermo Fisher Scientific Inc., Waltham, MA, USA) with a 
comparison according to the expected percentage of L-PRF. 
Induction was performed using differentiation media consisting of nutritional media (DMEM), 50 
μm/ml ascorbic acid-L diphosphate, 10 mM sodium glycerophosphate-β salt, and 10 μM dexamethasone. This 
differentiation medium was then mixed with 1%, 5%, 10%, or 25% L-PRF, or 10% FBS as a control, into wells 
containing 1 × 105 hDPSCs.  
The process of changing cells from hDPSCs to odontoblasts was characterized by TGF-β1 
expression, with cell morphology measured on day 7 in each test and control group. The amount of TGF-β1 
expression was measured using an ELISA reader. 
 
Data Analysis 
Retrieval of cell images was carried out using a microscope at 10× magnification before and after 
being treated for 7 days. Quantitative data from the results were statistically analyzed. The expression of 




On day 1, before being supplied with culture medium, cells consisted only of a monolayer, whereas by 
day 7, hDSPCs were developed into multilayers. There were significant differences between the L-PRF 
treatment groups and the control group (Table 1). 
 
Table 1. Average values of TGF-β1 expression (ng/ml) with different 
concentrations of L-PRF and the control group. 
Culture Media N Mean SD p-value 
FBS 10% 3 0.374 0.013 0.000* 
L-PRF 1% 3 0.160 0.045  
L-PRF 5% 3 0.275 0.045  
L- PRF 10% 3 0.461 0.035  
L- PRF 25% 3 0.645 0.048  
*One-way ANOVA Test. 
 
As seen in Table 2, according to the post hoc Bonferroni test, there were significant differences in 
average TGF-β1 expression (indicated by an asterisk). This showed that there was a significant difference 
between the control group (10% FBS) and the groups containing 1% and 25% L-PRF. Meanwhile, there were 
no significant differences between the control group (10% FBS) and the groups with 5% and 10% L-PRF. 
There were significant results among each group; 1% L-PRF and 10% L-PRF groups (p=0.033); 1% and 25% 
L-PRF groups (p=0.00); and 5% and 25% L-PRF groups (p=0.001). 
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Table 2. Analysis of TGF-β1 expression (ng/ml) with different L-PRF 
concentrations and the control group. 
Culture Media FBS 10% L-PRF 1% L-PRF 5% L-PRF 10% 
FBS 10%     
L-PRF 1% 0.033*    
L-PRF 5% 1.000 0.669   
L- PRF 10% 1.000 0.003* 0.076  
L- PRF 25% 0.007* 0.000* 0.001* 0.079 
*Post hoc Bonferroni test. 
 
Table 2 shows that an increase in the mean expression of TGF-β1 could be seen by day 7, with higher 
concentrations of L-PRF leading to greater expression of TGF-β1 being detected. The use of L-PRF with 
greater concentration produced TGF-β1 expression, which was better than 10% FBS as a control group. The 
highest TGF-β1 expression occurred with 25% L-PRF (0.645 ± 0.048), followed by 10% L-PRF (0.461 ± 
0.035), 10% FBS (0.374 ± 0.013), 5% L-PRF (0.275 ± 0.045), and the lowest expression was with 1% L-PRF 
(0.160 ± 0.045). 
 
Discussion 
This experimental laboratory study aimed to analyze differences in TGF-β1 expression during the 
differentiation process of hDPSCs when using various L-PRF concentrations. This study is a continuation of 
previous studies conducted by Saeed et al., which examined the potential of exudate 1%, 5%, 10% and 25% PRF 
toward differentiation of hDPSCs [8]. Another study compared the 20% L-PRF potential and 25% in the 
proliferation of hDPSCs, 25% L-PRF proved better than 20% L-PRF [11]. A recent study of A-PRF also 
showed that A-PRF has superior potential for supporting the proliferation of hDPSCs. The highest 
proliferation rate was seen with 25% A-PRF, while the lowest was seen with 10% A-PRF [12]. From these 
previous studies, it can be concluded that there was an excellent potential ability to modify PRF, such as 
exudate PRF, L-PRF and A-PRF, in proliferation and differentiation of hDPSCs. 
In this study, the potential ability of 1%, 5%, 10%, and 25% L-PRF in hDPSCs differentiation process 
was analyzed by examining TGF-β1 expression. The results of this study explained the transition from the 
process of proliferation to that of differentiation and how this was influenced by the expression of TGF-B1 by 
hDPSCs. It is assumed that the culture media used for hDPSC growth can influence TGF-β1 expression. In 
this study, therefore, the ability of various L-PRF concentrations related with TGF-β1 expression result was 
compared to find the optimal media for the differentiation process of hDPSCs [11]. 
Growth factors activate the signaling sequences necessary for the proliferation process to occur. Once 
a cell has divided into daughter cells and exited the cell cycle, there are several possibilities that may occur, 
including whether the cell can divide again, die via the process of apoptosis, enter senescence, or enter the 
phase of differentiation. The change from proliferation into differentiation depends on the presence of 
proliferation and activation factors of specific cell genes that can lead to different cells' formation [4]. DNA 
binding protein inhibitors (Id), known as an inhibitor of protein differentiation, play an important role in the 
proliferation of differentiation into differentiation. TGF-β can reduce the number of Id; this can inhibit the 
proliferation process and support the differentiation process [13,14]. 
The culture medium used in this study was PRF, which was modified by a freeze-thaw process to lyse 
platelets and collect the growth factors released; the result of this modification was named PRF lysate (L-
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PRF). L-PRF can release several growth factors, including VEGF, PDGF, TGF-β1, and EGF. TGF-β1 plays 
a vital role during the transition from proliferation to differentiation [9]. The results showed that more TGF 
β1 expression was detected at higher L-PRF concentrations. 
In this study, serum starvation was introduced by replacing the cell culture media supplement with 
1% FBS for 24 hours. This procedure was used to equalize the cells' conditions before treatment, so that they 
could be prepared in the desired condition. In current cell culture methods, basal media is provided with 
supplements containing growth factors, proteins, and enzymes that support cell proliferation and 
differentiation. FBS is the most commonly used supplement and has become the gold standard for culture 
media. FBS contains various substances dissolved in water, including nutrients, hormones, growth factors, 
protease inhibitors, and neutralizing toxins [15]. However, FBS has some deficiencies; e.g., it has been 
reported that FBS poses a risk of xenogenic reactions and may be also contaminated with bovine viruses that 
could cause an allergic response. This was supported by Asrianti et al. [16], who reported that human platelet 
lysate (hPL) might be an alternative culture media control in addition to FBS; it is shown that the proliferation 
of hDPSCs in 10% FBS compared with 5% hPL is comparable both showing good result. In this study, 
however, FBS was still used as the gold standard control [15,16]. 
Table 1 shows significant differences between 1%, 5%, 10%, and 25% L-PRF compared with the 
results of the control group (10% FBS). This result proved that the increase of L-PRF concentration was in 
line with the increase in TGF-β1 expression. TGF-β1 expression was directly proportional to the increase in 
L-PRF concentration. Conversely, compared with the 10% FBS control group, as seen in Table 1, TGF-β1 
expression with L-PRF was 10% and 25% higher than the FBS control group 10%. However, TGF-β1 L-PRF 
expression was 1% lower than the 10% FBS control group. Based on Table 2, the expression of TGF-β1 in the 
5% L-PRF group did not differ significantly compared with its expression in the 10% FBS control group. 
 
Conclusion 
There were significant differences in TGF-β1 expression among the 1%, 5%, 10%, and 25% L-PRF 
groups and the 10% FBS control group. The increasing concentration of L-PRF in line with the TGF-β1 
expression means that the higher the L-PRF concentration, the greater the expression of TGF-B1. Therefore, 
the best result of TGF-B1 expression in hDPSCs differentiation was in the 25% L-PRF group. 
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